News

Oximio Ukraine is represented at CTS Executive Board at EBA

We are delighted to announce that Oximio Ukraine is represented at the Clinical Trials Subcommittee (CTS) Executive Board at the European Business Association (EBA). Established in 1999, the EBA provides a forum in which members can discuss and find solutions to...

read more

Meet Oximio at GCSG US 2023

Global Clinical Supplies Group (GCSG) US Conference 23 – 26 April 2023, Orlando (USA)   Global Clinical Supplies Group (GSCG) will take place in Orlando (USA), bringing together clinical supply professionals. Each year, over 350 clinical supply professionals...

read more

Oximio support for Türkiye earthquake disaster

Oximio Community expresses its deepest condolences and supports the communities affected by the earthquake in Türkiye. We can confirm that our Oximio facility in Türkiye has not been affected, however we feel the pain and understand the devastation caused by this...

read more

New bonded depot in Serbia opens

We are delighted to share that expansion of our global bonded depot network continues.  We have successfully received the bonded depot license this week for our Serbia facility. This opens a route for imports of bulk shipments and distribution from our depot in Serbia...

read more

Oximio expands patient centricity services in Israel

As Oximio patient centricity services continue to expand, we are delighted to announce that the first home healthcare visit in Israel took place week commencing 9th of January 2023.The services allow for the nurses to collect the bio-samples from the patients’...

read more

Mykola Nikolaiev appointed Chief Executive Officer

  Following the announcement of 8th December 2022, the Board of Oximio confirms the appointment of Mykola Nikolaiev as the new Chief Executive Officer (CEO). Accordingly, Krisztina Varga has resigned from the Board as CEO and Mykola Nikolaiev takes over the...

read more